Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel (EDOX-APT): A Prospective Randomized Study
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Edoxaban (Primary) ; Aspirin; Clopidogrel
- Indications Thromboembolism
- Focus Pharmacodynamics
- Acronyms EDOX-APT
- 05 Apr 2018 Status changed from active, no longer recruiting to completed.
- 25 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2018.
- 25 Oct 2017 Status changed from recruiting to active, no longer recruiting.